New Delhi: Every day among the patients of the growing corona infection in the country, everyone is working to help in dealing with this problem in their own way. In this series, Indian pharmaceutical manufacturer Bajaj Healthcare Limited has announced success in making the drug Coronavirus. Bajaj Healthcare has said that it has launched a generic version of Favipiravir, an antiviral drug used to treat patients with corona infection. This drug of the company will be available in the form of a tablet in the name of Favijaj. This drug is considered effective in treating mild and moderate cases of Covid-19.
DCGI allowed the manufacture and marketing of favijaj
Bajaj Bajaj Healthcare informed Bombay Stock Exchange (BSE) that the drug regulator Drug Controller General of India (DCGI) has allowed it to produce and market favijaj in the country. Anil Jain, Joint Managing Director (Joint MD) of the company said that the availability of favijaj will help to overcome the shortage of Corona medicines in the country. Also, patients will get an effective option for treatment, which will reduce their difficulties. Let me tell you that at present, Remedisvir is considered to be the most effective drug in the treatment of corona patients, due to which it has decreased. In such a situation, this medicine can prove to be very helpful.
Bajaj Healthcare credited the research team for the preparation of the formula
Bajaj Healthcare says that it has formulated Favipiravir formulation for this tablet and its active pharmaceutical ingredient (API) through its own research. The credit goes to the company’s own research and development (R&D) team. Bajaj Healthcare shares closed at Rs 583.05, up 10.85 percent on the BSE today.
